Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy

  • 0The Maria Sklodowska-Curie National Research Institute of Oncology and Medical Center for Postgraduate Education, Warsaw, Poland (N.D.P., M.B., P.W., M.R., J.R.).

|

|

Summary

This summary is machine-generated.

A single negative colonoscopy significantly lowers colorectal cancer (CRC) risk and mortality. High-quality colonoscopy provides the most substantial and sustained protection against CRC incidence and death.

Area Of Science

  • Gastroenterology
  • Oncology
  • Preventive Medicine

Background

  • Current guidelines suggest 10-year intervals for screening colonoscopies, but supporting evidence is limited.
  • The long-term impact of screening colonoscopy quality on colorectal cancer (CRC) risk is not well-established.

Purpose Of The Study

  • To evaluate the long-term risk of colorectal cancer (CRC) and CRC-specific mortality following a single negative screening colonoscopy of either high or low quality.

Main Methods

  • An observational study of 165,887 average-risk individuals aged 50-66 years who underwent a single screening colonoscopy.
  • CRC incidence and mortality were compared to the general population using standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs).
  • High-quality colonoscopy was defined by complete examination, adequate bowel preparation, and an adenoma detection rate of ≥20% for the endoscopist.

Main Results

  • Over up to 17.4 years of follow-up, CRC incidence and mortality were 72% and 81% lower, respectively, compared to the general population.
  • High-quality colonoscopy was associated with a 2-fold reduction in CRC incidence and mortality compared to low-quality colonoscopy.
  • Hazard ratios for CRC incidence remained significantly lower after high-quality colonoscopy across all follow-up periods (0-5, 5.1-10, and 10-17.4 years).

Conclusions

  • A single negative screening colonoscopy is linked to reduced CRC incidence and mortality for up to 17.4 years.
  • High-quality colonoscopy is crucial for achieving significant and sustained reductions in CRC incidence and mortality.
  • These findings support the importance of colonoscopy quality in cancer prevention strategies.